Intervention not reported
Mortality for thrombotic events [ · patients with polycythaemia vera
The intervention probably leads to lower mortality for thrombotic events [ (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality for bleedings [ · patients with polycythaemia vera
1 finding from 1 review
Intervention not reported
All‐cause mortality [ · patients with polycythaemia vera
The intervention probably leads to lower all‐cause mortality [ (moderate certainty).
1 finding from 1 review
Intervention not reported
Major bleeding [ · patients with polycythaemia vera
The intervention probably leads to lower major bleeding [ (moderate certainty).
1 finding from 1 review
Intervention not reported
Minor bleeding [ · patients with polycythaemia vera
The intervention probably leads to higher minor bleeding [ (moderate certainty).
1 finding from 1 review
Overall survival number of dead patients · adults receiving treatment for follicular lymphoma
ACR showed no clear difference in overall survival number of dead patients compared with non‐ACR (moderate certainty).
1 finding from 1 review
Mortality at 3 years · adults receiving treatment for follicular lymphoma
ACR showed no clear difference in mortality at 3 years compared with non‐ACR (moderate certainty).
1 finding from 1 review
Overall response · adults receiving treatment for follicular lymphoma
ACR showed no clear difference in overall response compared with non‐ACR (moderate certainty).
1 finding from 1 review
Disease control number of patients with progression · adults receiving treatment for follicular lymphoma
ACR leads to lower disease control number of patients with progression compared with non‐ACR (high certainty).
1 finding from 1 review
Progression/relapse · adults receiving treatment for follicular lymphoma
ACR leads to lower progression/relapse at 3 years compared with non‐ACR (high certainty).
1 finding from 1 review
Grade 3 to 4 neutropenia · adults receiving treatment for follicular lymphoma
It is very uncertain whether ACR changes neutropenia grade 3‐4 compared with non‐ACR (very low certainty).
1 finding from 1 review
Cardiotoxicity ( · adults receiving treatment for follicular lymphoma
It is very uncertain whether ACR changes cardiotoxicity** compared with non‐ACR (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality (after 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention showed no clear difference in mortality (after 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Relapse or death (at 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention probably leads to lower relapse or death (at 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Treatment‐related mortality ‐ overall analysis (at 3 years) · Patients with refractory/relapsed Hodgkin lymphoma
The intervention showed no clear difference in treatment‐related mortality ‐ overall analysis (at 3 years) (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events not estimable · Patients with refractory/relapsed Hodgkin lymphoma
1 finding from 1 review
Intervention not reported
Quality of life not reported · Patients with refractory/relapsed Hodgkin lymphoma
1 finding from 1 review
Intervention not reported
Overall survival [range of median · patients with APL in first complete remission
The intervention may leads to lower overall survival [range of median (low certainty).
1 finding from 1 review
no estimate extracted
892 participants
Low
Intervention not reported
Subgroup analysis in pediatric patients: Overall survival [range of median · patients with APL in first complete remission
The intervention may leads to lower subgroup analysis in pediatric patients: Overall survival [range of… (low certainty).
1 finding from 1 review
no estimate extracted
133 participants
Low
Intervention not reported
Subgroup analysis in pediatric patients: Disease‐free survival [range of median · patients with APL in first complete remission
The intervention may leads to lower subgroup analysis in pediatric patients: Disease‐free survival… (low certainty).
1 finding from 1 review
no estimate extracted
127 participants
Low